Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin.
Targeting argininosuccinate synthetase negative melanomas using combination of arginine degrading enzyme and cisplatin. Oncotarget. 2015 Mar 20; 6(8):6295-309.